LG V700 Quick Start Guide - English - Page 29

National Institute for Occupational Safety and Health - case

Page 29 highlights

take action if tablets are shown to emit Radio Frequency (RF) energy at a level that is hazardous to the user. In such a case, the FDA could require the manufacturers of tablets to notify users of the health hazard and to repair, replace, or recall the tablets so that the hazard no longer exists. Although the existing scientific data does not justify FDA regulatory actions, the FDA has urged the tablet industry to take a number of steps, including the following: • Support needed research into possible biological effects of RF of the type emitted by tablets; • Design tablets in a way that minimizes any RF exposure to the user that is not necessary for device function; and • Cooperate in providing users of tablets with the best possible information on possible effects of tablet use on human health. The FDA belongs to an interagency working group of the federal agencies that have responsibility for different aspects of RF safety to ensure coordinated efforts at the federal level. The following agencies belong to this working group: • National Institute for Occupational Safety and Health • Environmental Protection Agency • Occupational Safety and Health Administration • National Telecommunications and Information Administration The National Institutes of Health participates in some interagency working group activities, as well. The FDA shares regulatory responsibilities for tablets with the Federal Communications Commission (FCC). All tablets that are sold in the United States must comply with FCC safety guidelines that limit RF exposure. The FCC relies on the FDA and other health agencies for 27

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90

27
take action if tablets are shown to emit Radio Frequency
(RF) energy at a level that is hazardous to the user. In
such a case, the FDA could require the manufacturers
of tablets to notify users of the health hazard and to
repair, replace, or recall the tablets so that the hazard no
longer exists.
Although the existing scientific data does not justify FDA
regulatory actions, the FDA has urged the tablet industry
to take a number of steps, including the following:
Support needed research into possible biological
effects of RF of the type emitted by tablets;
Design tablets in a way that minimizes any RF exposure
to the user that is not necessary for device function;
and
Cooperate in providing users of tablets with the best
possible information on possible effects of tablet use
on human health.
The FDA belongs to an interagency working group of
the federal agencies that have responsibility for different
aspects of RF safety to ensure coordinated efforts at
the federal level. The following agencies belong to this
working group:
National Institute for Occupational Safety and Health
Environmental Protection Agency
Occupational Safety and Health Administration
National Telecommunications and Information
Administration
The National Institutes of Health participates in some
interagency working group activities, as well.
The FDA shares regulatory responsibilities for tablets
with the Federal Communications Commission (FCC). All
tablets that are sold in the United States must comply
with FCC safety guidelines that limit RF exposure. The
FCC relies on the FDA and other health agencies for